March 30, 2023
Decibel Therapeutics
Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO
March 30, 2023
Flare Therapeutics
Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions
March 28, 2023
Voyager Therapeutics
Voyager Therapeutics Presents New Data Supporting Tau Antibody Program for Alzheimer’s Disease and GBA1 Gene Therapy Program for Parkinson’s Disease at the AD/PD™ Conference
March 27, 2023
Tango Therapeutics
Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights
March 22, 2023
Maze Therapeutics
Maze Therapeutics Announces New Clinical Data Supporting MZE001 as a Potential Treatment for Pompe Disease